Olpasiran
N/A
Report date: 2026/04/17 20:02:02
NME
Base Information
Drug NameOlpasiran
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[34]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesArrowhead Pharmaceuticals IncAmgen Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A